Related Experiment Video
Updated: Jun 16, 2026

Evaluating the Immune Response of a Nanoemulsion Adjuvant Vaccine Against Methicillin-Resistant Staphylococcus aureus (MRSA) Infection
Published on: September 1, 2023
Micro/nanoparticle adjuvants: preparation and formulation with antigens
Padma Malyala1, Manmohan Singh
1Novartis Vaccines and Diagnostics, Cambridge, MA, USA. Padma.malyala@novartis.com
Polylactide-co-glycolides (PLG) micro/nanoparticles effectively deliver and enhance vaccine antigens. Both particle types showed similar immunogenic responses in mouse models, highlighting their potential in vaccine development.
Area of Science:
- Biotechnology
- Vaccine Development
- Materials Science
Background:
- Recombinant proteins are promising vaccine antigens but often poorly immunogenic.
- Effective vaccine strategies require delivery systems and adjuvants to enhance antigen potency.
- Biodegradable polyesters like polylactide-co-glycolides (PLG) are suitable for these roles.
Purpose of the Study:
- To discuss the application of PLG micro/nanoparticles as antigen delivery systems and adjuvants.
- To detail the synthesis and characterization methods for PLG-based vaccine components.
- To compare the immunogenic potential of PLG microparticles versus nanoparticles.
Main Methods:
- PLG microparticles synthesized via solvent evaporation.
- PLG nanoparticles prepared using a solvent displacement method.
- Characterization of micro/nanoparticles with adsorbed antigens.
Main Results:
- PLG nanoparticles offer simpler synthesis and sterile filtration compared to microparticles.
- Both PLG microparticles and nanoparticles demonstrated comparable immunogenic responses in a mouse model.
- Detailed materials and methods for synthesis and characterization are provided.
Conclusions:
- PLG micro/nanoparticles are versatile platforms for vaccine antigen delivery and adjuvantation.
- The choice between micro- and nanoparticles may depend on specific formulation and manufacturing considerations.
- Further research into optimizing PLG-based vaccine systems is warranted.
More Related Videos
06:02Cationic Nanoemulsion-Encapsulated Retinoic Acid as an Adjuvant to Promote OVA-Specific Systemic and Mucosal Responses
Published on: February 23, 2024
11:07Whole-animal Imaging and Flow Cytometric Techniques for Analysis of Antigen-specific CD8+ T Cell Responses after Nanoparticle Vaccination
Published on: April 29, 2015